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Netherlands
Objective: Systemic lupus erythematosus (SLE) is an autoimmune disease character-
ized by the presence of autoantibodies against nuclear components. Lupus nephritis 
(LN) is the major cause of morbidity and mortality in patients with SLE. Central to the 
pathogenesis of SLE is the accumulation of cellular waste, especially apoptotic micro-
particles (MPs), which stimulates diverse immune reactions including the formation of 
neutrophil extracellular traps (NETs). In this study, we investigated the content of MPs 
from SLE patients with and without (active) LN, their capacity to stimulate NET release, 
and assessed the molecular mechanisms underlying MP-induced NETosis.
Methods: MPs from SLE patients with biopsy-proven active LN, remissive LN, without 
LN, and healthy controls were characterized by flow cytometry. Isolated neutrophils 
were exposed to MPs derived from either patient plasma or apoptotic human umbilical 
vein endothelial cells, and NET release was quantified by immunofluorescence imaging, 
spectrofluorometry or an in-house developed NET ELISA.
results: MPs from SLE patients with active LN contain higher levels of acetylated 
chromatin compared to MPs from those with remissive LN, without LN, or healthy con-
trols. MPs enriched in hyperacetylated chromatin are more potent in inducing NETosis 
when compared to MPs containing moderate acetylated chromatin. The release of 
NETs in response to MPs occurs rapidly in a concentration-dependent manner and 
proceeds independent from the formation of reactive oxygen species (ROS).
conclusion: Our data suggest that MPs containing acetylated chromatin drive ROS-
independent NET release in SLE patients with active LN, which may lead to the glomer-
ular deposition of NETs and subsequent NET-driven LN.
Keywords: neutrophil extracellular traps, microparticles, lupus nephritis, acetylated histones, systemic lupus 
erythematosus, neTosis
inTrODUcTiOn
Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by the presence of 
autoantibodies against nuclear antigens, such as nucleosomes, DNA, and histones (1). Immune 
complexes of autoantibodies and chromatin form depositions and trigger serious inflammatory 
conditions in multiple organs, including lupus nephritis (LN) in the kidneys. LN is a major cause 
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of morbidity and mortality in patients with SLE and causes pro-
teinuria and a gradual decline of kidney function (2–4). During 
the disease course, states of quiescent disease can alternate with 
periods of active disease, the so-called flares. Although the trig-
gers of these flares are largely unknown, they lead to increased 
production of autoantibodies and enhancement of inflammatory 
processes (5–7).
The presence of nuclear antigens in the circulation of patients 
with SLE can be explained by increased apoptosis and/or an 
impaired clearance of apoptotic cells. Apoptotic cell-derived 
constituents within the extracellular space trigger immune reac-
tions by innate and adaptive immune cells (8–11). Apoptotic cells 
can give rise to the formation of microparticles (MPs), which 
are small vesicles generally defined as <1 μm in size, that carry 
a range of immunostimulatory proteins, including apoptosis-
modified chromatin enriched in methylated and particularly 
acetylated histone residues (12–14). MPs have been identified 
and characterized in plasma of SLE patients and were previously 
shown to be highly pro-inflammatory (15–18). Autoantibodies 
against these apoptosis-associated histone modifications can be 
found in patients with SLE, suggesting that these modifications 
play a role in breaking the immune tolerance (5, 19–21).
In addition to apoptosis, abnormalities in the formation and 
degradation of neutrophil extracellular traps (NETs) have been 
linked to the autoimmune response in SLE and LN (22). NETs 
are formed during a specialized cell death program of neutro-
phils, termed NETosis and are generally described as web-like 
structures composed of DNA and antimicrobial proteins, e.g., 
myeloperoxidase (MPO) and neutrophil elastase (NE) (23). 
Although being essential for antimicrobial defense, NETs can 
also cause tissue damage and evoke autoimmune responses, when 
persistently present in the extracellular space (24, 25).
Recently, we showed that MPs from patients with SLE but not 
MPs from patients with other autoimmune diseases can activate 
blood-derived dendritic cells and induce the formation of NETs 
(15). However, the reason for the increased immunogenicity of 
MPs from patients with SLE remained unanswered. Moreover, 
the mechanisms by which MPs induce NET formation remained 
to be established. In this study, we investigated the mechanisms 
and clinical relevance of MP-induced NETosis in SLE.
MaTerials anD MeThODs
human Material
Blood samples were collected from SLE patients and healthy 
controls that either participated in the Dutch SLE Nephritis 
Study (26) or in subsequent studies at the Radboud university 
medical center, The Netherlands. All patients fulfilled at least 
four American College of Rheumatology criteria for SLE. 
Patients were either defined as patients with (i) active LN, 
(ii) remissive LN, or (iii) without LN. Patients with active LN 
were defined as having glomerular hematuria or proteinuria of 
≥0.5  g/24  h and LN was confirmed by renal biopsy. Patients 
with active LN were longitudinally followed and new blood 
was retrieved at the time proteinuria was ≤0.5  g/24  h and/
or hematuria had disappeared (remissive LN). Patients with 
LN were treated with cyclophosphamide or a combination of 
azathioprine and methylprednisolone pulses, both combined 
with oral prednisone until reaching criteria for remission. 
Blood samples of patients categorized as active LN were col-
lected before the start of treatment. Clinical parameters, such 
as C3 levels, anti-dsDNA titers, creatinine, and proteinuria, and 
SLE disease activity index [SLEDAI (27)] were determined in 
our diagnostic facility by routine measurements (Table S1 in 
Supplementary Material). The collection of blood samples was 
approved by the ethics committees of all participating hospitals 
and the study has been carried out in compliance with the 
Helsinki declaration. Written informed consent was obtained 
from all subjects.
isolation of MPs
Blood was centrifuged for 10 min at 3,000 × g and platelet-poor 
plasma was stored at −80°C until further use. For the isolation of 
plasma-derived MPs, plasma was diluted in PBS and centrifuged 
for 5 min at 500 × g at 4°C. Subsequently, the supernatant was 
centrifuged 10 min at 20,800 × g at 4°C.
In Vitro generation of endothelial  
cell-Derived apoptotic MPs
Human umbilical vein endothelial cells (HUVECs) were 
maintained in fibronectin-coated Corning cell culture flasks 
(Sigma-Aldrich) in EGM-2-medium supplemented with 2% 
FCS and EGM-2 SingleQuots (Lonza) and cultured with 5% 
CO2 at 37°C. Apoptosis in HUVECs was induced by 10  µM 
4 Nitroquinoline 1 oxide (4-NQO; Sigma-Aldrich) for 24  h. 
Culture supernatants were then centrifuged (5 min, 500 × g, 4°C) 
followed by an additional centrifugation step (10  min, 
20,800 × g, 4°C) to pellet endothelial cell-derived MPs. Where 
indicated, HUVECs were pretreated with the histone deacety-
lase inhibitor trichostatin A (TSA) (Sigma-Aldrich) for 24  h 
prior to the induction of apoptosis to generate MPs enriched in 
hyperacetylated chromatin.
Flow cytometry
Isolated MPs were washed with PBS containing 0.1% bovine 
serum albumin (PBA), and incubated for 30 min at 4°C with the 
monoclonal anti-histone antibodies KM-2 [anti-H4K8,12,16Ac 
(12)] and LG11-2 [anti-H2BK12Ac (13)] or their appropriate 
isotype controls (UPC-10; Sigma). MPs were subsequently 
incubated for 30  min at 4°C with Alexa Fluor 488-conjugated 
goat anti-mouse IgG (Thermo Fisher Scientific). Finally, MPs 
were extensively washed and resuspended in PBA and analyzed 
using a FC500 flow cytometer (Beckman Coulter). For determi-
nation of MP concentrations, AccuCheck calibrated beads were 
added according to the manufacturer’s protocol (Thermo Fisher 
Scientific).
isolation of neutrophils and induction  
of neTosis
Neutrophils were isolated by Ficoll density gradient centrifuga-
tion using Lymphoprep™ (Stemcell Technologies), as described 
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previously (28). Isolated neutrophils (3 × 105 cells per cm2) were 
seeded in serum-free DMEM/F12 (Sigma-Aldrich) and exposed 
to MPs at indicated concentrations. Addition of 100 nM PMA 
(Sigma-Aldrich) or activated platelets to neutrophil cultures 
served as positive controls for NETosis induction. Platelets were 
isolated and activated with lipopolysaccharide (LPS, O111:B4, 
Sigma-Aldrich), as described previously (29). Where indicated, 
neutrophils were pretreated for 1  h with the ROS-inhibitor 
diphenyleneiodonium (40 µM, DPI, Enzo Life Sciences) prior to 
the addition of MPs or PMA.
Quantification of neTs
After stimulation of neutrophils, adherent NETs were isolated 
by partially digesting the NETs in DMEM/F12 medium (Life 
Technologies) supplemented with 5 U/ml micrococcal nuclease 
(Worthington Biochemical Corporation). NET-derived DNA was 
incubated with 200 nM Sytox Orange (Thermo Fisher Scientific) 
and detected using a Tecan Infinite 200 multimode reader (Tecan 
industries). For the in-house developed NET ELISA, soluble 
NET fragments were captured using an anti-dsDNA antibody 
[antibody #36, mouse IgG2a, 1:4,000 (30)], blocked with 2% 
fish gelatin (Sigma-Aldrich), and detected with an anti-MPO 
antibody (mouse IgG1, 1:6,000, Biolegend). A horseradish 
peroxidase conjugated antibody (goat anti-mouse IgG1, 1:5,000, 
Jackson Immunoresearch) was used to detect the anti-MPO 
antibody. TMB substrate (Biolegend) was added according to the 
manufacturer’s instructions for 12 min. The reaction was stopped 
by adding 2  M sulfuric acid and absorbance was measured at 
450 nm using a Spectophotometer (Benchmark Plus, Biorad).
immunofluorescence Microscopy
Purified neutrophils (10 × 105 cells per cm2) were seeded in slide-
flask chambers (Thermo Scientific) and exposed to MPs. After 
stimulation, cells and NETs were fixed in 4% paraformaldehyde 
(15 min, 4°C), and slides were stained for DNA (Sytox Orange; 
200 nM), NE (1:200, Abcam), and/or MPO (1:400, Biolegend). 
Goat anti-rabbit and goat anti-mouse antibodies labeled with 
Alexa Fluor 488 (1:200, Thermo Fisher Scientific) were used to 
detect anti-NE and anti-MPO, respectively. Slides were embed-
ded in Vectashield Mounting Medium (Brunschwig Chemie), 
and pictures were obtained with a Zeiss fluorescence microscope 
with Axiovision soſtware.
Dnase activity
DNA degradation was assessed according to the protocol of 
Hakkim et  al. (22) with slight modifications. Briefly, NET-
associated DNA or calf thymus-derived DNA was adjusted to a 
concentration of 500 ng/ml and incubated with 10% recalcified 
plasma. After 180 min of incubation at 37°C, the remaining DNA 
was quantified with 200 nM Sytox Orange using fluorometry.
statistical analyses
Data are reported as the means ± SEM of at least three experi-
ments. Significance was determined by the appropriate statistical 
tests as specified in the figure legends. Correlation was analyzed 
using Spearman’s correlation coefficient. GraphPad Prism 
software (Version 5.03) was used for statistical testing. p values 
less than 0.05 were considered as statistically significant.
resUlTs
MPs from Patients with active ln are 
enriched in acetylated chromatin
We have previously described that SLE patients-derived MPs are 
capable of enhancing NETosis in neutrophils (15). Since aberrant 
NETosis has been particularly associated with the development 
of LN in SLE, we explored whether MPs from SLE patients with 
active LN differ and have a different NETosis-inducing capacity 
when compared to MPs from SLE patients with remissive LN or 
without LN. Therefore, we isolated MPs from the same patients 
at different time points, during active LN and after reaching 
remission. MPs isolated from patients during active LN showed 
an increased reactivity with the anti-histone antibodies KM-2 
and LG11-2, targeting apoptosis-induced acetylated histone H4 
(at K8,12,16) and H2B (at K12), respectively, when compared 
to MPs from the same patients during remissive LN or patients 
without LN (Figures 1A–C). Furthermore, MPs from patients 
with active LN showed a higher forward and side scatter 
compared to MPs from patients with remissive LN or without 
LN (Figures  1D,E), suggesting that these MPs originate from 
apoptotic cells, since they are generally larger in size and have 
more content compared to MPs derived from resting or acti-
vated cells (31). Importantly, the total number of MPs did not 
significantly differ between all groups (Figure 1F). In summary, 
circulating MPs in patients with active LN are relatively large 
and have more apoptosis-associated chromatin modifications, 
which decline during the remission of LN and are even lower in 
patients without LN.
hUVec-Derived MPs induce neTosis  
in a concentration-Dependent Manner
We previously showed that apoptotic MPs in SLE patients 
predominantly originate from endothelial cells (15). Others 
also reported that the number of endothelial cell-derived MPs 
increases during active disease (32). Therefore, we used in vitro 
generated MPs derived from apoptotic HUVECs as a model 
to study the mechanisms involved in MP-induced NETosis. 
HUVEC-derived MPs contained apoptotic chromatin modifica-
tion as defined by KM-2 (Figures  2A,B) and showed forward 
and side scatter characteristics similar to MPs isolated from 
patients with SLE (Figures  2C,D). HUVEC-derived MPs were 
internalized and induced NETosis in neutrophils isolated from 
healthy donors as visualized by immunofluorescence microscopy 
(Figure 2E; Figure S1 in Supplementary Material). Neutrophils 
stimulated with HUVEC-derived MPs extrude fine stretches 
of DNA decorated with MPO and NE (Figure  2E; Figure S2A 
in Supplementary Material). The induction of NETosis by 
HUVEC-derived MPs appeared to be concentration-dependent 
as quantified by NET ELISA and Sytox staining (Figure  2F; 
Figure S2B in Supplementary Material). Together, these data 
indicate that HUVEC-derived MPs can be used as a model to 
study MP-induced NETosis in SLE.
FigUre 1 | Continued
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FigUre 2 | Microparticles (MPs) from apoptotic endothelial cells induce NETosis. (a) Human umbilical vein endothelial cell (HUVEC)-derived MPs stained for 
H4K8,12,16Ac (KM-2) and measured using flow cytometry corrected for isotype staining. Mean KM-2 staining (B), forward scatter (c), side scatter (D) of 
HUVEC-derived MPs (n = 4) MPs isolated from patients with active lupus nephritis (LN) (n = 18) and healthy donors (n = 11). Note that data concerning 
active LN patients and healthy donors are the same data as displayed in Figure 1. (e) Neutrophils isolated from healthy donors were either left unstimulated 
(left panel) or were co-incubated with HUVEC-derived MPs (right panel). Samples were fixed and stained for DNA (Sytox) and myeloperoxidase (MPO). 
HUVEC MPs induce the formation of neutrophil extracellular traps (NETs) identified by colocalization of MPO and DNA (right panel, arrows). (F) Different 
concentration of HUVEC-derived MPs were incubated with isolated neutrophils and NET formation was measured using a NET-specific ELISA (n = 4 
experiments). Data are represented for each patient separately with median (B–D) and mean with SEM (F). Scale bar: 50 µm. *p < 0.05, **p < 0.01, 
***p < 0.001 compared to unstimulated control (F) by Student’s t test or compared to all other conditions (B–D) by one-way ANOVA with Bonferroni-
corrected post hoc test.
FigUre 1 | Continued  
Degree of acetylation of histones in microparticles (MPs) isolated from patients with systemic lupus erythematosus (SLE) is increased during active lupus 
nephritis (LN). (a) Representative flow cytometer plots of one patient showing MPs stained for acetylated histone H4K8,12,16 (left panel; stained with 
monocolonal antibody KM-2) and acetylated histone H2BK12 (right panel; stained with monoclonal antibody LG11-2) during active and remissive period of 
disease. (B,c) Mean fluorescence intensity of MPs stained for H4K8,12,16Ac (B) and H2BK12Ac (c) corrected for isotype staining from patients with active 
LN (n = 18) compared to patients with LN at remission (n = 18) or patients without LN (n = 18) and normal healthy controls (NHD; n = 11). (D,e) Mean side 
and forward scatter of unstained MPs. (F) MP count in plasma as determined using counting beads. Data are presented for each patient separately with 
indication of the median of the groups. *p < 0.05, **p < 0.01, ***p < 0.001 compared to active disease patients, determined by Kruskal–Wallis test followed by 
Dunn’s post hoc test. #p < 0.05, ##p < 0.01 compared to active disease patients by paired Student’s t test (B) and Wilcoxon matched-pairs signed rank test 
in (c–e).
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FigUre 3 | Human umbilical vein endothelial cell (HUVEC)-derived microparticles (MPs) induce a fast and ROS-independent NETosis mechanism. 
(a,B) Neutrophils were stimulated with HUVEC-derived MPs, platelets activated with lipopolysaccharide (LPS), or PMA and analyzed at different time points. 
(a) Samples were fixed and stained for myeloperoxidase (MPO) and DNA (Sytox). Arrows indicate neutrophil extracellular trap (NET) formation. (B) NET 
formation as measured using a NET-specific ELISA (n = 4 experiments). (c,D) Neutrophils were left untreated or were preincubated with diphenyleneiodonium 
(DPI) and subsequently stimulated with PMA or HUVEC-derived MPs for 3 h. (c) Immunofluorescent images stained for MPO and DNA (Sytox, arrows indicate 
NETs). (D) NETosis quantified by a NET-specific ELISA (n = 3 experiments). Data are presented as mean with SEM. Scale bar: 50 µm. *p < 0.05, **p < 0.01, 
***p < 0.001 tested by two-way ANOVA with Bonferroni-corrected post test compared to control (B) one-way ANOVA followed by Bonferroni-corrected 
post hoc test (D).
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hUVec MPs induce a Fast and  
rOs-independent neTosis Mechanism
NETosis was initially described as a ROS-dependent cell death 
pathway (23), but other reports showed that NETs can also be 
released rapidly in a ROS-independent manner (33). For instance, 
activated platelets rapidly trigger ROS-independent NETosis 
(29, 34). We observed that HUVEC-derived MPs induced NETosis 
already within 30 min of incubation, with the difference compared 
to the control being significant from 60 min onward (Figure 3B). 
Over the time course of 3  h, MP-stimulated neutrophils only 
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show a minor increase in NET production similar to the control 
situation. By contrast, exposure of neutrophils to PMA, a fre-
quently used stimulus for ROS-dependent NETosis, resulted in 
only minor NET release after 1 h and most NETs were produced 
between 1 and 3 h of stimulation (Figures 3A,B; Figures S3A,B in 
Supplementary Material). Furthermore, exposure of neutrophils 
to PMA resulted in the complete rupture of nearly all neutrophils, 
as observed by immunofluorescence microscopy (Figure  3A), 
whereas HUVEC-derived MPs and LPS-activated platelets 
resulted in the release of NET-like structures without evidently 
altering neutrophil morphology (Figure 3A). Finally, inhibition 
of ROS by DPI could not inhibit NET release in response to 
HUVEC-derived MPs, whereas the release of NETs in response 
to PMA was reduced by DPI (Figures 3C,D; Figures S3C,D in 
Supplementary Material). In summary, HUVEC-derived MPs 
rapidly induce NETosis in a ROS-independent manner, which is 
fundamentally different from PMA-induced NETosis.
acetylated histones contribute to the 
neTosis-inducing capacity of MPs
Acetylated histones have immunostimulatory potential and 
appear to play a role in the pathogenesis of SLE (12, 28). We 
hypothesized that acetylated histones within apoptotic cell-
derived MPs determine their potency to induce NETosis. 
To investigate this, we treated HUVECs with the histone 
deacetylase inhibitor TSA prior to the induction of apoptosis 
and the isolation of HUVEC-derived MPs. In this way, we 
generated HUVEC-derived apoptotic MPs containing increased 
amounts of hyperacetylated histones compared to normal 
apoptotic HUVEC-derived MPs (Figure 4A). Indeed, hypera-
cetylated MPs led to a further increase in NET production, 
compared to normally acetylated MPs (Figures  4B,C; Figure 
S4 in Supplementary Material). Plasma-derived MPs from 
patients with active LN displayed the highest acetylation levels 
(Figures  1B,C) and were more potent stimulators of NETosis 
compared to MPs from SLE patients without LN or MPs from 
NHDs (Figure 4D). In addition, ProtK-mediated degradation 
of all proteins, including histones, present in MPs diminished 
their potency to induce NETosis (Figure  4E, Figure S5 in 
Supplementary Material). Taken together, the presence of acety-
lated histones within HUVEC- or SLE-derived MPs contributes 
to the NETosis-inducing capacity of MPs.
Dnase activity is impaired in Patients  
with ln
DNase activity is important for the degradation of both NET-
derived as well as MP-derived chromatin (22, 35). It appeared 
that patients with LN (both active and remissive) were impaired 
in their capacity to degrade NETs (Figure 5A) as well as nuclear 
DNA (Figure 5B), as has also been reported earlier (22, 36). In 
addition, DNase activity inversely correlated with the amount 
of acetylated histones in MPs (Figures  5C,D), suggesting that 
patients with an impaired DNase activity also fail to degrade 
apoptotic cell-derived chromatin in vivo. Altogether, these data 
implicate that patients with LN fail to degrade extracellular 
chromatin.
DiscUssiOn
An imbalance between the formation and clearance of apoptotic 
cells in SLE causes the persistent presence of apoptotic debris, 
including cell-derived MPs, in the extracellular space. Circulating 
MPs in SLE patients are considered pro-inflammatory, and pre-
viously we showed that SLE-derived MPs have the capacity to 
enhance NETosis in blood-derived neutrophils (15). In this study, 
we describe that the presence of hyperacetylated chromatin in 
MPs is a critical determinant for the NETosis-inducing capacity 
of MPs in SLE patients with active LN.
A unique feature of MPs released from dying cells is that 
they contain nuclear components, such as histones and DNA, 
which carry apoptotic modifications (37). Furthermore, MPs 
derived from apoptotic cells tend to be bigger compared with 
MPs released from living cells (31). We found that MPs present 
in patients with active LN showed a relatively high reactivity with 
anti-histone antibodies recognizing apoptosis-associated histone 
modifications and had on average a larger forward and side scat-
ter on flow cytometric analysis. Together, these findings suggest 
that apoptotic cells contribute to a considerable extent to the 
generation of MPs in patients with LN. The degree of apoptotic 
histone modifications found in MPs declined during remission of 
LN and was much lower in SLE patients without LN.
The presence of apoptotic cell-derived MPs in SLE patients 
with active LN has been linked to tissue damage induced by for 
example sun burns (38). In addition, apoptotic cell-derived MPs 
could be a reflection of an ongoing state of inflammation and tis-
sue damage elsewhere. We propose that the presence of apoptotic 
cell-derived MPs in the circulation also gives rise to a pathogenic 
feed forward loop by interacting with circulating neutrophils and 
triggering NET release. Aberrant NET release and the failure of 
endonucleases to degrade NETs have previously been linked to 
SLE and LN (22, 39). We show that SLE patients with either active 
or remissive LN fail to degrade NET-derived chromatin, whereas 
SLE patients without LN are capable of degrading NETs. Thus, an 
impaired endonuclease activity is typical for SLE patients with LN 
or SLE patients with increased SLEDAI and other non-renal clini-
cal complications (40). Undegraded NETs can ultimately deposit 
in the glomerular capillaries, where they may exacerbate renal 
inflammation by activation of complement via bound Ig, or by 
their cytotoxic histones and/or cytotoxic enzymes (e.g., MPO, NE) 
(41–43). This is in line with findings of circulating NET fragments 
and skin or renal NET depositions in lupus-prone mice and SLE 
patients (44), suggesting a pathogenic involvement of NETs in SLE.
A key finding of our study is that the presence of acetylated 
histones within the MPs is crucial for the induction of NETosis. 
The presence of acetylated histones within MPs inversely cor-
related with endonuclease activity in the plasma, suggesting that 
endonucleases are involved in the degradation of both NET-
derived chromatin and chromatin present within apoptotic cell-
derived MPs. Recent studies indicated that the failure to digest 
chromatin in MPs leads to autoimmunity and the induction of 
SLE (35). Apoptosis-associated histone modifications increase 
the immunostimulatory potential of histones, and anti-histone 
antibodies in SLE patients show an increased reactivity with 
modified histones compared to their unmodified counterparts (5). 
FigUre 4 | Continued
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FigUre 5 | DNase activity is impaired in patients with lupus nephritis (LN). (a,B) Plasma of patients with active LN (n = 18), remissive LN (n = 18), systemic lupus 
erythematosus (SLE) patients without LN (n = 18), and NHD (n = 11) were incubated with neutrophil extracellular traps (NETs) (a) or DNA from calf thymus  
(B). DNase activity is expressed as the percentage of degraded nucleic acid, measured by Sytox orange, after incubation with plasma. (c,D) Correlation of DNase 
activity on degradation of NETs with chromatin content of microparticles as measured using flow cytometry. Data are presented for each patient separately with 
indication of the median of the groups. ***p < 0.001 determined by one-way ANOVA followed by Bonferroni-corrected post hoc test. Correlations are reported as 
Spearman correlation coefficients.
FigUre 4 | Continued  
Degree of histone acetylation in microparticles (MPs) determines their NETosis-inducing capacity. (a) MPs isolated from human umbilical vein endothelial cell 
(HUVEC) treated with trichostatin A (TSA) or left untreated before induction of apoptosis stained for H4K8,12,16Ac (KM-2; left panel) and H2BK12Ac (LG11-2; 
right panel) and measured using flow cytometry. (B) MPs from TSA-treated HUVEC and normal MPs were co-incubated with isolated neutrophils and samples 
were stained for myeloperoxidase (MPO) and DNA [Sytox, arrows indicate neutrophil extracellular traps (NETs)]. (c) Different concentrations of MPs from TSA 
treated HUVECs and normal MPs were co-incubated with neutrophils and NETosis was measured using a NET-specific ELISA (n = 4). (D) MPs with high (n = 4) 
and low acetylation scores (KM-2, n = 4) in each patient group were pooled and co-incubated with neutrophils. NETs were quantified by a NET specific ELISA. 
(e) HUVEC MPs were treated with proteinase K resulting in MPs without proteins, before co-incubating with neutrophils (n = 3 experiments). Data are presented 
as mean with SEM. Scale bar: 50 µm. *p < 0.05, **p < 0.01, ***p < 0.001 determined by two-way or one-way ANOVA with Bonferroni-corrected post hoc test 
and Student’s t test.
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We previously described that hyperacetylated nucleosomes show 
an increased capacity to activate bone-marrow derived dendritic 
cells when compared to non-acetylated nucleosomes. Moreover, 
administration of an acetylated histone H4 peptide to lupus-
prone mice enhanced proteinuria, skin lesions, and mortality, 
whereas its non-acetylated counterpart had not such effects (12). 
Acetylated histones can be sensed via toll-like receptors 2 and 
4 (TLRs) (45), both of which are expressed by neutrophils. 
Therefore, it is tempting to speculate that TLR signaling is 
involved in MP-induced NETosis.
We found that NETosis in response to hyperacetylated his-
tones occurred rapidly and proceeded in a ROS-independent 
manner. Although many NET-inducing agents typically cause 
ROS-dependent NETosis (46), recently a number of stimuli have 
been shown to promote NET formation without a requirement 
of ROS production (29, 34). Furthermore, lupus-prone mice 
deficient in ROS have markedly exacerbated lupus, including 
increased autoantibody profiles as well as renal disease, question-
ing the contribution of ROS-dependent NETosis to the pathogen-
esis of SLE (47). Therefore, we propose that ROS-independent 
FigUre 6 | Schematic overview of proposed mechanism of microparticle (MP)-induced NETosis in patients with lupus nephritis (LN). Cells undergoing apoptosis 
release MPs containing hyperactylated histones (1). In patients with LN MPs accumulate in the circulation and trigger neutrophils to undergo NETosis (2). Since 
DNase activity is impaired in LN patients, neutrophil extracellular traps (NETs) are not properly degraded (3). NETs deposit in the glomerular capillaries and induce 
tissue injury and inflammations leading to nephritis and further cell death (4).
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NETosis driven by circulating MPs is promoting the pathogenesis 
of SLE.
Whether the NET release after stimulation by apoptotic cell-
derived MPs has a physiological meaning is unclear. NETosis 
was originally described as an antimicrobial defense strategy 
that is triggered by molecules derived from foreign (intrud-
ing) pathogens. However, many host-derived molecules (e.g., 
HMGB1, uric acid) have been identified as NET-inducing stimuli 
(48, 49). NETs can also function as a transient barrier during 
tissue injury, a process in which debris released from dying cells 
triggers NETosis and the aggregation of NETs, thereby isolating 
injured tissue and limiting the spread of cell death-associated 
pro-inflammatory mediators (50, 51). It remains speculative 
that the MP-induced NETosis finds it origin in aforementioned 
mechanism.
In conclusion, we show that MPs induce the formation of 
NETs in SLE patients with LN. The degree of acetylated chro-
matin present in the MPs determines their potency to stimulate 
neutrophils to go into NETosis. We propose that during active 
LN, apoptotic cell-derived MPs are formed. Without the proper 
functioning of endonucleases, MPs enriched in apoptosis-
associated histone modifications persist within the circulation, 
thereby triggering NETosis and further kidney damage when 
the formed NETs deposit in the renal capillaries. This causes 
further release of apoptotic cell-derived MPs, thereby establish-
ing a vicious pathogenic circle (Figure 6).
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